BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23064545)

  • 1. Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study.
    Ahmadzadehfar H; Meyer C; Ezziddin S; Sabet A; Hoff-Meyer A; Muckle M; Logvinski T; Schild HH; Biersack HJ; Wilhelm K
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):80-90. PubMed ID: 23064545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in normal liver and spleen volume after radioembolization with (90)Y-resin microspheres in metastatic breast cancer patients: findings and clinical significance.
    Paprottka PM; Schmidt GP; Trumm CG; Hoffmann RT; Reiser MF; Jakobs TF
    Cardiovasc Intervent Radiol; 2011 Oct; 34(5):964-72. PubMed ID: 21748452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Cone-Beam Tomography and Cross-Sectional Imaging for Volumetric and Dosimetric Calculations in Resin Yttrium-90 Radioembolization.
    Ertreo M; Choi H; Field D; Lischalk JW; Cohen E; Lynskey GE; Caridi T; Buckley D; Unger K; Kim AY
    Cardiovasc Intervent Radiol; 2018 Dec; 41(12):1857-1866. PubMed ID: 30006891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma.
    Goebel J; Sulke M; Lazik-Palm A; Goebel T; Dechêne A; Bellendorf A; Mueller S; Umutlu L; Theysohn J
    PLoS One; 2017; 12(7):e0181488. PubMed ID: 28708902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer.
    Sabet A; Meyer C; Aouf A; Sabet A; Ghamari S; Pieper CC; Mayer K; Biersack HJ; Ezziddin S
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):370-6. PubMed ID: 25351506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.
    Rhee TK; Lewandowski RJ; Liu DM; Mulcahy MF; Takahashi G; Hansen PD; Benson AB; Kennedy AS; Omary RA; Salem R
    Ann Surg; 2008 Jun; 247(6):1029-35. PubMed ID: 18520231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
    Karunanithy N; Gordon F; Hodolic M; Al-Nahhas A; Wasan HS; Habib N; Tait NP
    Cardiovasc Intervent Radiol; 2011 Apr; 34(2):287-94. PubMed ID: 20700593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.
    van den Hoven AF; Rosenbaum CE; Elias SG; de Jong HW; Koopman M; Verkooijen HM; Alavi A; van den Bosch MA; Lam MG
    J Nucl Med; 2016 Jul; 57(7):1014-9. PubMed ID: 26912436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging.
    Wong CY; Qing F; Savin M; Campbell J; Gates VL; Sherpa KM; Lewandowski RJ; Nagle C; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1101-6. PubMed ID: 16105922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early metabolic response assessment of breast cancer liver metastases: 4-week posttreatment FDG PET predicts survival after 90Y microsphere radioembolization.
    Sabet A; Ries M; Al-Khalaf Y; Meyer C; Rudlowski C; Simon B; Khreish F; Ezziddin S
    Nuklearmedizin; 2019 Jun; 58(3):242-248. PubMed ID: 31167272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: implications for planning 90Y radioembolization?
    Burgmans MC; Too CW; Kao YH; Goh AS; Chow PK; Tan BS; Tay KH; Lo RH
    Eur J Radiol; 2012 Dec; 81(12):3979-84. PubMed ID: 22954411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis.
    Pieper CC; Willinek WA; Thomas D; Ahmadzadehfar H; Essler M; Nadal J; Wilhelm KE; Schild HH; Meyer C
    Eur Radiol; 2016 Aug; 26(8):2779-89. PubMed ID: 26560720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization with 90Y resin microspheres for HCC patients with extensive tumor thrombosis into the extrahepatic vessels.
    Ahmadzadehfar H; Pieper CC; Ezziddin S; Biersack HJ; Meyer C
    Clin Nucl Med; 2014 Mar; 39(3):305-7. PubMed ID: 24458185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Y-90 Radioembolization After Prior Major Hepatic Resection.
    Zimmermann M; Schulze-Hagen M; Liebl M; Pedersoli F; Goerg F; Ulmer TF; Heinzel A; Isfort P; Kuhl C; Bruners P
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1206-1212. PubMed ID: 28357572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver radioembolization using 90Y resin microspheres in elderly patients: tolerance and outcome.
    Iñarrairaegui M; Bilbao JI; Rodríguez M; Benito A; Sangro B
    Hosp Pract (1995); 2010; 38(3):103-9. PubMed ID: 20890058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.
    Barabasch A; Kraemer NA; Ciritsis A; Hansen NL; Lierfeld M; Heinzel A; Trautwein C; Neumann U; Kuhl CK
    Invest Radiol; 2015 Jun; 50(6):409-15. PubMed ID: 25763526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric injury from (90)Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction?
    Gates VL; Hickey R; Marshall K; Williams M; Salzig K; Lewandowski RJ; Salem R
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2038-44. PubMed ID: 26194715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-MAA/ 90Y-Bremsstrahlung SPECT/CT after simultaneous Tc-MAA/90Y-microsphere injection for immediate treatment monitoring and further therapy planning for radioembolization.
    Ahmadzadehfar H; Sabet A; Muckle M; Wilhelm K; Reichmann K; Biersack HJ; Ezziddin S
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1281-8. PubMed ID: 21359611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the parenchymal blood volume by C-arm computed tomography for radioembolization dosimetry.
    Grözinger G; Kupferschläger J; Dittmann H; Maurer M; Grosse U; la Fougère C; Nikolaou K; Syha R; Ketelsen D
    Eur J Radiol; 2016 Sep; 85(9):1525-31. PubMed ID: 27501884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A descriptive analysis of remnant activity during (90)Y resin microspheres radioembolization of hepatic tumors: technical factors and dosimetric implications.
    Rodríguez LS; Thang SP; Li H; Khor LK; Tay YS; Myint KO; Tong AK
    Ann Nucl Med; 2016 Apr; 30(3):255-61. PubMed ID: 26692012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.